Malignant hyperthermia (MH) is a rare pharmacogenetic disorder, resulting in excessive Ca2+ release from the sarcoplasmic reticulum after activation of the abnormal ryanodine receptor (RYR1 encoded by the RYR1 gene). This evidence concerns the gene RYR1 and Malignant hyperthermia.